BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18972327)

  • 1. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?
    Atherly A; Dowd B
    Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should healthy Medicare beneficiaries postpone enrollment in Part D?
    Federowicz M
    Find Brief; 2008 Nov; 11(9):1-4. PubMed ID: 19035030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.
    Domino ME; Stearns SC; Norton EC; Yeh WS
    Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Part D plan enrollment by uninsured medicare beneficiaries.
    Maciejewski ML; Farley JF; Hansen RA; Wei D; Harman JS
    Med Care; 2010 Feb; 48(2):183-6. PubMed ID: 20057332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost minimization of medicare part D prescription drug plan expenditures.
    Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
    Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
    Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-pocket pharmacy expenditures for veterans under medicare part D.
    Rupper RW; Bair BD; Sauer BC; Nebeker JR; Shinogle J; Samore M
    Med Care; 2007 Oct; 45(10 Supl 2):S77-80. PubMed ID: 17909387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model.
    Cutler TW; Stebbins MR; Smith AR; Patel RA; Lipton HL
    Med Care; 2011 Apr; 49(4):343-7. PubMed ID: 21407030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of drug consumption patterns for Medicare Part D patients.
    Pedan A; Lu J; Varasteh LT
    Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health plan decision making in the Medicare population: results from a national randomized experiment.
    McCormack LA; Anderson WL; Uhrig JD; Garfinkel SA; Sofaer S; Terrell SA
    Health Serv Res; 2001 Dec; 36(6 Pt 2):133-49. PubMed ID: 16148965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prescription drug coverage on the cost of care to Medicare beneficiaries with asthma.
    Atherly A
    Expert Rev Pharmacoecon Outcomes Res; 2004 Aug; 4(4):421-8. PubMed ID: 19807301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in out-of-pocket healthcare costs among older community-dwelling Medicare beneficiaries.
    Riley GF
    Am J Manag Care; 2008 Oct; 14(10):692-6. PubMed ID: 18837647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.